ALBERT WONG
Broker in Somerville, MA
License number
Massachusetts 89645
Issued Date
Sep 1, 1986
Expiration Date
Jan 11, 1991
Type
Salesperson
Address
Address
Somerville, MA 02145
Professional information
Albert Wong - Somerville, MA
Work:
Fidelity Investments
Senior Fund Accountant CITY OF FITCHBURG - Fitchburg, MA
City Auditor Intern
Senior Fund Accountant CITY OF FITCHBURG - Fitchburg, MA
City Auditor Intern
Education:
FITCHBURG STATE UNIVERSITY - Fitchburg, MA
BA in Economics, Minors in International Studies and Business Adminsitration
BA in Economics, Minors in International Studies and Business Adminsitration
Skills:
Microsoft Access, Microsoft Excel, Microsoft PowerPoint, Microsoft Word, Bloomberg, Fluent in Conversational Cantonese
Method For Surgical Treatment Of Occlusive Disease
US Patent:
2010004, Feb 25, 2010
Filed:
Feb 26, 2009
Appl. No.:
12/393039
Inventors:
Albert Wong - Somerville MA, US
International Classification:
A61M 29/00, A61F 2/82
US Classification:
606195, 623 115
Abstract:
A method of surgically treating occlusive disease in an intraluminal tissue using both a retractor () and a retractable one-piece stent. The stent is constructed and arranged such that it can exist in at least a stable initial collapsed state () and a stable deployed expanded state (). In conjunction with the retractor, the stent is positioned at an appropriate location within an occluded intraluminal tissue and converted from a stable initial collapsed state to a stable deployed expanded state, and is then converted to a collapsed state and removed before significant restenosis occurs.
Growth Factor Sensitive Vesicle
US Patent:
2009027, Nov 5, 2009
Filed:
Jan 9, 2009
Appl. No.:
12/350961
Inventors:
Albert Wong - Somerville MA, US
International Classification:
A61K 9/127, A61P 35/00
US Classification:
424450
Abstract:
A generally spherical growth factor sensitive vesicle bearing growth factor receptors () having chemical compounds () covalently cross-linked to their non-growth factor binding domains. The chemical compounds are capable of associating to form larger chemical compounds () capable of destabilizing the vesicle. Methods for treating growth factor-overexpressing neoplasms are disclosed.